Emodin inhibits proliferation and drug efflux, enhances Cisplatin (DDP)-induced apoptosis and DNA damage, and decreases P-gp protein expression in a dose-dependent manner in NSCLC (A549 and H460) cells. Here, PGP is linked to non-small cell lung carcinoma.